Filter Results:
(347)
Show Results For
- All HBS Web
(586)
- People (4)
- News (151)
- Research (347)
- Events (2)
- Multimedia (4)
- Faculty Publications (172)
Show Results For
- All HBS Web
(586)
- People (4)
- News (151)
- Research (347)
- Events (2)
- Multimedia (4)
- Faculty Publications (172)
Sort by
- 13 Jan 2003
- Research & Ideas
Making Biotech Work as a Business
technologies for drug discovery.) And patients with previously unmet medical needs can now get treatments that were not available before. That should be inspiring, he reminded the audience. Economic frustrations remain, however. Pisano... View Details
- 29 May 2001
- Research & Ideas
Genomics: Can We Start Making Money Now?
said. The potential influence on drug development in particular, and medicine in general, is enormous, panelists agreed. Today's drugs can reach some 400 to 500 potential... View Details
Keywords: by Sean Silverthorne
- 20 Nov 2006
- Research & Ideas
Open Source Science: A New Model for Innovation
innovation and product development strategies. His latest research analyzes how open source norms of transparency, permeable access, and collaboration might work with scientists. What he and his coauthors discovered:... View Details
Keywords: by Martha Lagace
- 30 Mar 2010
- First Look
First Look: March 30
GordonHarvard Business School Case 810-066 In May 2007, Amgen Inc. (Amgen) received disappointing news from the European Medicines Agency (EMEA) that its drug Vectibix, developed to fight metastatic... View Details
Keywords: Sean Silverthorne
- 01 Jun 2009
- Lessons from the Classroom
The Challenges of Investing in Science-Based Innovation
she adds, with the development of a vaccine against cervical cancer (Gardasil) and the launch of successful new drugs to combat diabetes and HIV/AIDS. Sato acknowledges that different situations will require... View Details
- 25 Apr 2005
- Research & Ideas
New Learning at American Home Products
pharmaceuticals, it concentrated on enlarging its OTC business by, as before, exploiting its advertising skills. By 1979 it had developed a broader line of new prescription drugs, beginning in 1968 with Inderal, a beta-blocker View Details
- 08 Dec 2003
- Research & Ideas
Why Europe Lags in Pharmaceuticals and Biotech
pharma," said HBS professor Regina Herzlinger, moderating a panel discussion titled "Pharma and Biotech—Where does Europe Stand in the World?" The discussion was held at the conference on November 22. At the start of the 1990s, the U.S. and European... View Details
- 11 Aug 2003
- Research & Ideas
Cheap, Fast, and In Control: How Tech Aids Innovation
product and service development is changing; creating the potential for higher R&D performance, innovation, and value creation for customers. The choice is simple: Organizations can either ignore these changes or take action and tap... View Details
Keywords: by Wendy Guild
- 09 Sep 2014
- First Look
First Look: September 9
Battilana, Julie, and Matthew Lee Abstract—Hybrid organizations that combine multiple organizational forms deviate from socially legitimate templates for organizing and thus experience unique organizing challenges. In this paper, we introduce and View Details
Keywords: Sean Silverthorne
- 28 Oct 2014
- First Look
First Look: October 28
disruptive to its drug development efforts and delay new drugs coming to market. UK politicians expressed concerns over downsizing and job losses in the economically important... View Details
Keywords: Carmen Nobel
- 18 Nov 2014
- First Look
First Look: November 18
innovative drug candidates for testing in patients. Project teams consisted of Pfizer scientists and academics working side-by-side to reduce the time needed to bring a therapeutic drug from the lab to a... View Details
Keywords: Sean Silverthorne
- 27 Mar 2012
- First Look
First Look: March 27
biopharmaceutical industry's transformation from the mid-1970s through 2001, including the rising cost and complexity of drug development and the remarkably slow pace of IT adoption in clinical trials.... View Details
Keywords: Carmen Nobel
- 02 Sep 2008
- First Look
First Look: September 3, 2008
Exercise of Leadership, a New Model Authors:Werner Erhard, Michael C. Jensen, Steve Zaffron, Kari L. Granger Abstract This paper is the (pre-course) introduction document to an experimental course developed by the authors and taught at... View Details
Keywords: Sean Silverthorne
- 24 Mar 2020
- Research & Ideas
These Coronavirus Heroes Show Us How Crisis Leadership Works
Schinecker, CEO of Roche Diagnostics, leads a company that received the FDA’s first emergency use authorization for a commercially developed COVID-19 test on March 13. Roche now believes it can ship up to 400,000 test kits per week.... View Details
- 18 Aug 2011
- Lessons from the Classroom
Business Plan Contest: 15 Years of Building Better Entrepreneurs
in 2001 with Alec Machiels (MBA '01) at the helm, its plan hinged on a mechanism created by a team of Harvard and MIT scientists that used atomic force microscopy in drug research. "A number of the scientists decided that being part of a... View Details
- 28 Apr 2009
- First Look
First Look: April 28, 2009
consumer-oriented model for drug development and use has attracted attention in recent years as an alternative to the much-maligned approach of mass-marketing blockbuster drugs. In a parallel development,... View Details
Keywords: Martha Lagace
- 18 Jun 2001
- Research & Ideas
When In-House Research Isn’t Enough
For many decades, corporate research and development has been pretty much an "inside job." The road to innovative new products and services began and ended with a company's internal R&D. But according to HBS assistant... View Details
Keywords: by Jim Aisner
- 23 Mar 2003
- Research & Ideas
AIDS in Africa—What’s the Solution?
teachers to talk about AIDS prevention, the government can use a built-in educational infrastructure. Ngozi Edozien Ngozi Edozien, vice president of PPG Planning and Business Development for Pfizer, said the lack of a delivery... View Details
Keywords: by Julie Jette
- 08 Mar 2016
- First Look
March 8, 2016
cultural model and undermine their own positions with inappropriate use of symbolic market-creation actions. Download working paper: https://www.hbs.edu/faculty/Pages/item.aspx?num=50701 Harvard Business School Case 916-026 Express Scripts: Promoting Prescription View Details
Keywords: Sean Silverthorne
- 30 Jun 2003
- Research & Ideas
Computer Security is For Managers, Too
Most organizations already have at least some of these processes in place, but they rarely develop and manage them in a coherent, consistent way. Here are eight things that your company should be working on. Identify your company's... View Details